Vivesto Stock

Vivesto EBIT Margin

EBIT Margin (Operating Margin) of Vivesto (VIVE.ST) as of Aug 10, 2026.

EBIT Margin

0.00

Last updated:

EBIT Margin (Operating Margin) of Vivesto is 2026 0.00 . EBIT Margin (Operating Margin) of Vivesto was 2025 -356.49 % . It decreases by % higher compared to the previous year.

For Vivesto, the operating (EBIT) margin of -35,648.6% is down versus -7,613.6% a few years ago.

Access this data via the Eulerpool API

Vivesto Stock analysis

What does Vivesto do? Oasmia Pharmaceutical AB is a Swedish pharmaceutical company that specializes in the development and marketing of innovative cancer and pain medications. The company was founded in 1998 and is headquartered in Uppsala, Sweden. Vivesto is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vivesto stock

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Vivesto since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Vivesto with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

Margins — Vivesto

All Key Metrics — Vivesto